Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Nov-14 5:37 PM View:  | Fuhrman Alan Chief Financial Officer | Ambit Biosciences Corporation (AMBI) | 10-Nov-14 | Disposition | 6,309 | $15.00 | $94,635.00 | (100%) 6.31K to 0 | |
| 22-Dec-14 12:26 PM View: | Marchington Allan P Director | Ambit Biosciences Corporation (AMBI) | 10-Nov-14 | Disposition | 1,396,490 | $15.00 | $20,947,300.00 | (100%) 1.4M to 0 | |
| 04-Sep-14 8:28 PM View: | Elms Steve Director | Ambit Biosciences Corporation (AMBI) | 02-Sep-14 | Exercise (in-the money or at-the-money) | 2,362 | $6.66 | $15,730.90 | < 1% 1.65M to 1.65M | |
| 16-Oct-13 12:26 PM View: | Foresite Capital Management... 10% Owner | Ambit Biosciences Corporation (AMBI) | 24-Jun-13 | Market Purchase | 4,817 | $6.77 | $32,593.70 | < 1% 2.07M to 2.08M | 21% |
| 16-Oct-13 12:26 PM View: | Foresite Capital Management... 10% Owner | Ambit Biosciences Corporation (AMBI) | 14-Jun-13 | Market Purchase | 7,500 | $7.46 | $55,962.00 | < 1% 2.07M to 2.07M | 9% |
| 16-Oct-13 12:26 PM View: | Foresite Capital Management... 10% Owner | Ambit Biosciences Corporation (AMBI) | 12-Jun-13 | Market Purchase | 5,700 | $7.45 | $42,483.20 | < 1% 2.06M to 2.07M | 9% |
| 16-Oct-13 12:26 PM View: | Foresite Capital Management... 10% Owner | Ambit Biosciences Corporation (AMBI) | 03-Jun-13 | Market Purchase | 10,000 | $6.99 | $69,908.00 | < 1% 2.05M to 2.06M | 17% |
| 24-May-13 5:29 PM View: | Orbimed Advisors LLC 10% Owner | Ambit Biosciences Corporation (AMBI) | 23-May-13 | Market Purchase | 12,500 | $6.99 | $87,366.20 | < 1% 1.48M to 1.49M | 17% |
| 24-May-13 5:30 PM View: | Bonita David P Director 10% Owner | Ambit Biosciences Corporation (AMBI) | 23-May-13 | Market Purchase Duplicate | 12,500 | $6.99 | $87,366.20 | < 1% 1.48M to 1.49M | 17% |
| 24-May-13 5:30 PM View: | Bonita David P Director 10% Owner | Ambit Biosciences Corporation (AMBI) | 22-May-13 | Market Purchase Duplicate | 21,300 | $6.86 | $146,139.00 | 1% 1.46M to 1.48M | 19% |
| 16-Oct-13 12:26 PM View: | Foresite Capital Management... 10% Owner | Ambit Biosciences Corporation (AMBI) | 22-May-13 | Market Purchase | 5,005 | $6.74 | $33,729.20 | < 1% 2.05M to 2.05M | 21% |
| 24-May-13 5:29 PM View: | Orbimed Advisors LLC 10% Owner | Ambit Biosciences Corporation (AMBI) | 22-May-13 | Market Purchase | 21,300 | $6.86 | $146,139.00 | 1% 1.46M to 1.48M | 19% |
| 23-May-13 5:11 PM View: | Elms Steve Director | Ambit Biosciences Corporation (AMBI) | 22-May-13 | Exercise (in-the money or at-the-money) | 103,712 | $0.02 | $2,489.09 | 7% 1.55M to 1.65M | |
| 21-May-13 7:43 PM View: | Marchington Allan P Director | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Conversion | 895,294 | -- | -- | 401477% 0.22K to 895.52K | |
| 22-May-13 7:07 PM View: | Bonita David P Director 10% Owner | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Conversion Duplicate | 776,189 | -- | -- | 7115% 10.91K to 787.1K | |
| 21-May-13 7:45 PM View: | Elms Steve Director | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Purchase | 423,635 | $8.00 | $3,389,080.00 | 38% 1.12M to 1.55M | |
| 16-Oct-13 12:26 PM View: | Foresite Capital Management... 10% Owner | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Purchase | 1,811 | $6.84 | $12,380.40 | < 1% 2.04M to 2.05M | |
| 21-May-13 7:45 PM View: | Elms Steve Director | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Conversion | 1,122,590 | -- | -- | 512598% 0.22K to 1.12M | |
| 21-May-13 7:41 PM View: | Fleming Standish Director | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Purchase | 263,301 | $8.00 | $2,106,410.00 | 37% 702.85K to 966.15K | |
| 22-May-13 5:42 PM View: | Orbimed Advisors LLC 10% Owner | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Purchase | 669,871 | $7.99 | $5,350,030.00 | 85% 787.1K to 1.46M | |
| 21-May-13 7:41 PM View: | Fleming Standish Director | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Conversion | 702,710 | -- | -- | 520526% 0.14K to 702.85K | |
| 22-May-13 5:42 PM View: | Orbimed Advisors LLC 10% Owner | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Conversion | 776,189 | -- | -- | 7115% 10.91K to 787.1K | |
| 21-May-13 7:43 PM View: | Marchington Allan P Director | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Purchase | 431,527 | $8.00 | $3,452,220.00 | 48% 895.51K to 1.33M | |
| 22-May-13 7:07 PM View: | Bonita David P Director 10% Owner | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Purchase Duplicate | 669,871 | $7.99 | $5,350,030.00 | 85% 787.1K to 1.46M | |
| 22-May-13 7:07 PM View: | Bonita David P Director 10% Owner | Ambit Biosciences Corporation (AMBI) | 20-May-13 | Purchase Duplicate | 10,600 | $6.78 | $71,839.40 | 3430% 0.31K to 10.91K | |
| 16-Oct-13 12:26 PM View: | Foresite Capital Management... 10% Owner | Ambit Biosciences Corporation (AMBI) | 20-May-13 | Purchase | 8,120 | $6.90 | $56,048.30 | < 1% 2.04M to 2.04M | |
| 22-May-13 5:42 PM View: | Orbimed Advisors LLC 10% Owner | Ambit Biosciences Corporation (AMBI) | 20-May-13 | Purchase | 10,600 | $6.78 | $71,839.40 | 3430% 0.31K to 10.91K | |
| 16-Oct-13 12:26 PM View: | Foresite Capital Management... 10% Owner | Ambit Biosciences Corporation (AMBI) | 17-May-13 | Purchase | 36,616 | $6.77 | $247,953.00 | 2% 2.0M to 2.04M |
